Acute Kidney Injury (AKI)

Definition | Aetiology | Pathophysiology | Risk Factors | Signs and Symptoms | Investigations | Classification | Management

Definition

Acute Kidney Injury (AKI) is a sudden decline in kidney function over hours to days, leading to an accumulation of waste products, electrolyte disturbances, and fluid imbalance.

It is defined by any of the following:

  • Increase in serum creatinine by ≥26.5 μmol/L within 48 hours.
  • Increase in serum creatinine to ≥1.5 times baseline within 7 days.
  • Urine output <0.5 mL/kg/hour for >6 hours.

Aetiology

1. Pre-Renal AKI (Hypoperfusion, Most Common Cause):

  • Hypovolaemia (e.g., dehydration, haemorrhage).
  • Cardiac failure (e.g., heart failure, cardiogenic shock).
  • Sepsis (systemic vasodilation reduces renal perfusion).
  • Renal artery stenosis.

2. Intrinsic (Renal) AKI:

  • Acute tubular necrosis (ATN) – ischemia or nephrotoxins (e.g., NSAIDs, aminoglycosides).
  • Glomerulonephritis (autoimmune or infectious).
  • Acute interstitial nephritis (e.g., due to drugs, infections).
  • Rhabdomyolysis (muscle breakdown releasing nephrotoxic myoglobin).

3. Post-Renal AKI (Obstructive):

  • Kidney stones.
  • Benign prostatic hyperplasia (BPH).
  • Bladder outlet obstruction.
  • Tumours (e.g., prostate, bladder).

Pathophysiology

  • Pre-renal AKI leads to reduced glomerular filtration rate (GFR) due to hypoperfusion.
  • Intrinsic AKI results from direct nephron injury (e.g., ischemia, toxins).
  • Post-renal AKI involves obstruction, leading to back pressure and tubular dysfunction.
  • If untreated, AKI can progress to chronic kidney disease (CKD) or end-stage renal failure.

Risk Factors

  • Age >65 years.
  • Chronic kidney disease (pre-existing kidney disease increases risk).
  • Diabetes mellitus.
  • Heart failure or liver disease.
  • Sepsis.
  • Use of nephrotoxic medications (e.g., NSAIDs, ACE inhibitors, diuretics, contrast agents).
  • Major surgery (post-operative AKI risk).
  • Hypovolaemia or dehydration.

Signs and Symptoms

Early Symptoms:

  • Reduced urine output (oliguria <400 mL/day or anuria <100 mL/day).
  • Fatigue, nausea, and confusion.
  • Signs of fluid overload (oedema, pulmonary congestion).

Severe AKI Symptoms:

  • Hyperkalaemia (can cause cardiac arrhythmias).
  • Metabolic acidosis (Kussmaul breathing).
  • Uraemia (causing confusion, pruritus, and asterixis).

Investigations

  • Serum creatinine: defines AKI based on rise from baseline.
  • U&Es (Urea and Electrolytes): assess sodium, potassium, and creatinine.
  • Urinalysis: detects blood, protein, or infection.
  • Urinary sodium and osmolality: differentiates pre-renal from intrinsic AKI.
  • Renal ultrasound: assesses obstruction (hydronephrosis suggests post-renal AKI).
  • ECG: check for hyperkalaemia-related arrhythmias (peaked T waves, widened QRS).

Classification

Stage Serum Creatinine Urine Output
AKI 1 1.5–1.9 times baseline OR ≥26.5 μmol/L rise <0.5 mL/kg/hr for 6–12 hours
AKI 2 2.0–2.9 times baseline <0.5 mL/kg/hr for ≥12 hours
AKI 3 ≥3.0 times baseline OR ≥354 μmol/L <0.3 mL/kg/hr for ≥24 hours OR anuria for ≥12 hours

Management

1. General Measures:

  • Identify and treat the underlying cause.
  • Monitor fluid balance: avoid overhydration in oliguric AKI.
  • Stop nephrotoxic drugs: NSAIDs, ACE inhibitors, aminoglycosides.
  • Optimise blood pressure: maintain adequate perfusion.

2. Fluid Management:

  • Pre renal AKI: IV fluids (e.g., 0.9% saline) if hypovolaemic.
  • Fluid overload: consider furosemide (loop diuretics).

3. Electrolyte Management:

  • Hyperkalaemia (K+ >6.0 mmol/L): treat with calcium gluconate, insulin/dextrose, and consider dialysis if severe.
  • Metabolic acidosis: sodium bicarbonate if severe.

4. Dialysis Indications ("AEIOU"):

  • A: Acidosis (pH <7.1).
  • E: Electrolytes (severe hyperkalaemia >6.5 mmol/L).
  • I: Intoxications (e.g., lithium, methanol).
  • O: Overload (refractory pulmonary oedema).
  • U: Uraemia (symptomatic, e.g., pericarditis, encephalopathy).